Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1002902110 | 10029021 | 10 | F | 201402 | 20160926 | 20140321 | 20160930 | EXP | PHHY2014CA032261 | NOVARTIS | 84.62 | YR | F | Y | 64.85000 | KG | 20160930 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1002902110 | 10029021 | 1 | PS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 300 UG, BID | 57600 | UG | Y | U | 19667 | 300 | UG | BID | |||
| 1002902110 | 10029021 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (ONCE A MONTH) | 0 | 30 | MG | SUSPENSION | /month | ||||||
| 1002902110 | 10029021 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, EVERY 25 DAYS | 0 | 30 | MG | SUSPENSION | |||||||
| 1002902110 | 10029021 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, TIW (EVERY 3 WEEKS) | 0 | 30 | MG | SUSPENSION | Q3W | ||||||
| 1002902110 | 10029021 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | U | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1002902110 | 10029021 | 1 | Neuroendocrine tumour |
| 1002902110 | 10029021 | 2 | Neuroendocrine tumour |
| 1002902110 | 10029021 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1002902110 | 10029021 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1002902110 | 10029021 | Atrial fibrillation | |
| 1002902110 | 10029021 | Blood pressure increased | |
| 1002902110 | 10029021 | Diarrhoea | |
| 1002902110 | 10029021 | Heart rate increased | |
| 1002902110 | 10029021 | Injection site discolouration | |
| 1002902110 | 10029021 | Injection site mass | |
| 1002902110 | 10029021 | Intestinal obstruction | |
| 1002902110 | 10029021 | Nervousness | |
| 1002902110 | 10029021 | Pain | |
| 1002902110 | 10029021 | Tension | |
| 1002902110 | 10029021 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1002902110 | 10029021 | 1 | 20131211 | 20140331 | 0 | |
| 1002902110 | 10029021 | 2 | 20140318 | 20141127 | 0 | |
| 1002902110 | 10029021 | 3 | 20141223 | 20160830 | 0 | |
| 1002902110 | 10029021 | 4 | 20160923 | 0 |